Number of carvedilol prescriptions in the U.S. 2004-2016

Number of carvedilol prescriptions in the U.S. from 2004 to 2016 (in millions)

by Matej Mikulic, last edited Nov 14, 2018
Number of carvedilol prescriptions in the U.S. 2004-2016 This statistic shows the total annual number of carvedilol prescriptions in the U.S. from 2004 to 2016, in millions. In 2004, carvedilol was prescribed over 8 million times. As of 2016 the number of carvedilol prescriptions had increased to over 23 million. Carvedilol is a beta blocker used for treating mild to severe congestive heart failure (CHF), left ventricular dysfunction (LVD) following heart attack in people who are otherwise stable, and for treating high blood pressure.
Show more

Number of carvedilol prescriptions in the U.S. from 2004 to 2016 (in millions)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "U.S. pharmaceutical industry"
  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
  • Generics
  • Outlook
  • The consumer's view
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.